EcoDrugPlus

Ensembl ID : ENSSLDG00000019502
Gene Symbol: -
Cross references: -
387 Possible Orthologues:

Ensembl ID : ENSSLDG00000001383
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSSLDG00000001222
Gene Symbol: -
Cross references: -
375 Possible Orthologues:

Ensembl ID : ENSSLDG00000001142
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSSLDG00000008019
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSSLDG00000019469
Gene Symbol: -
Cross references: -
335 Possible Orthologues:

Ensembl ID : ENSSLDG00000000668
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSSLDG00000023314
Gene Symbol: -
1 Cross references
233 Possible Orthologues:

Ensembl ID : ENSSLDG00000008915
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Ensembl ID : ENSSLDG00000023244
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSSLDG00000013511
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSSLDG00000008562
Gene Symbol: -
Cross references: -
7 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).